Coronavirus

Israel Chemicals Donates Money, Swabs to Bolster Battle Against Covid-19 in Israel

ICL has donated NIS 900,000 (approximately $247,000) and 20,000 swabs to Israeli hospitals Soroka University Medical Center in Israel's southern city Be'er Sheva and Chaim Sheba Medical Center at Tel HaShomer for their efforts in countering the virus

Tel Aviv-headquartered Israel Chemicals Ltd. (ICL), with the help of the regional managers of its factories in China, is importing 20,000 swabs for the diagnosis of coronavirus (Covid-19) cases in Israel, the company announced Sunday. ICL also donated NIS 900,000 (approximately $247,000) to Israeli hospitals Soroka University Medical Center in Israel's south and Chaim Sheba Medical Center in the Tel Aviv area.

 

The swabs, for which the company reported cost of NIS 200,000 (approximately $50,000), were pre-approved by Israel’s Ministry of Health.

 

ICL CEO Raviv Zoller. Photo: Amit Sha'al

Dually-listed on the NYSE and the Tel Aviv Stock Exchange, ICL is an industrial company focusing on agriculture, food, and engineered materials. The company is controlled by its largest shareholder, Tel Aviv-listed Israel Corporation Ltd. ICL employs more than 11,000 people, and its 2019 revenue totaled approximately $5.3 billion.